Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Half of the year is over! So, which pharmaceutical giant outpaces the others? Sharp investors wonder whose market ...

NEW YORK (AP) — U.S. stocks climbed further into record heights on Thursday after a report showed the U.S. job market looks ...

Innovation in obesity treatments, Alzheimer's detection and medical-device applications is setting the stage for a number of ...

A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?

NEW YORK (AP) — Stocks rose in afternoon trading Friday and put Wall Street on track to close a strong week at an all-time ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

It would behoove more Americans to learn how consistent seafood consumption has strong potential to ward off coronary disease ...

Eli Lilly’s first quarter saw rapid revenue growth, but the market responded negatively due to profit shortfalls and emerging ...